Page 10 - Truth Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Youth urged to venture into farming April 21, 2021 Mr Ayaba The youth have been urged to venture into farming for wealth creation and the promotion of food security in the country. Describing the sector as profitable, the Chief Executive Officer (CEO) of The Truth Farms (TTF), a subsidiary of The Truth Group of Companies, Mr Mohammed Ayaba, who gave the advice in an interview with the Ghanaian Timesencouraged the populace to see farming as a business capable of alleviating poverty. He bemoaned the unwillingness of most Ghanaian youth to take up farming despite the venture being capab...

Number of Shares and Voting Rights of ADOCIA as of February 28th, 2021 Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities ( Autorité des Marchés Financiers, or "AMF") charter ADOCIA SA (Paris:ADOC), a French société anonyme (corporation), 115, avenue Lacassagne, 69003 Lyon, (Euronext Paris: FR0011184241 ADOC) a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, releases its total number of outstanding shares as wel...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Evoke Pharma Reports Fourth Quarter and Full Year 2020 Financial Results Evoke Pharma, Inc.March 11, 2021 GMT SOLANA BEACH, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced its financial results for the fourth quarter ended December 31, 2020 and recent corporate developments. “Despite the challenges precipitated by the COVID-19 pandemic, 2020 proved t...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2020 Financial Results OrthoPediatrics Corp.March 10, 2021 GMT Full year 2020 revenue of $71.1m compared to full year 2019 revenue of $72.6m, reflecting the impact of COVID-19 on elective surgeries Guidance for full year 2021 sales growth in the range of 31-38%, reaching $93-98 million WARSAW, Ind., March 10, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusi...

Adocia Initiates Phase 2 Clinical Trial for M1Pram in Patients with Type 1 Diabetes 1c The study has been designed to define parameters for the upcoming Phase 3 trial planned for 2022 This study follows the promising results of the proof-of-concept Phase 1 trial announced on September 15, 2020 Regulatory News: Adocia (Paris:ADOC) (Euronext Paris: FR0011184241 ADOC), a clinical stage biopharmaceutical company focused on diabetes treatment and other metabolic diseases, announced today the initiation of a Phase 2 study in type 1 diabetes (T1D). The purpose of the study is to confirm and optimize...